Tang Capital Management LLC Albireo Pharma, Inc. Transaction History

Tang Capital Management LLC

  • $1.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$18.01 - $23.78 $5.19 Million - $6.85 Million
-288,032 Reduced 41.15%
411,968 $8.9 Million
Q2 2022

Aug 15, 2022
BUY
$18.54 - $37.29 $4.31 Million - $8.66 Million
232,298 Added 49.67%
700,000 $13.9 Million
Q1 2022

May 16, 2022
BUY
$23.94 - $33.74 $11.2 Million - $15.8 Million
467,702 New
467,702 $14 Million

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email